Torys LLP | Canada | 30 Jan 2013
On January 18, 2013, the Federal Court of Appeal (FCA) released its decision in Takeda Canada Inc. v. The Minister of Health and Attorney General of…
Torys LLP | Canada | 14 Feb 2012
In a recent decision – Celgene Inc. v. Canada (Minister of Health) – the Federal Court of Canada declared that a drug containing a previously approved medicinal ingredient is nevertheless subject to data protection.
Torys LLP | Canada | 25 Jul 2011
Canada has one of the world’s largest medical device markets, estimated at C$6 billion in 2010, with sales of almost C$3 billion taking place in Ontario.
Torys LLP | Canada | 6 Apr 2011
Pharmaceutical and medical device companies doing business with Ontario organizations that accept public funding, including hospitals, may be affected by recent legislative amendments aimed at increasing transparency and accountability of these entities.
Torys LLP | Canada | 12 Mar 2010
Health Canada has indicated that it plans to release an updated notice on classifying patient management software in the coming weeks, modifying the notice it released on August 31, 2009.